Document:

Purchase Agreement

 EXHIBIT 10.1 
  
 EXECUTION COPY 
  
 STOCK PURCHASE AGREEMENT 
  
 This STOCK PURCHASE AGREEMENT (this “Agreement”) is dated as of the 24th day of August 2005 (the “Effective Date”) by and between REGENERATION TECHNOLOGIES, INC., a Delaware corporation with its principal office at
11621 Research Circle, Alachua, Florida 32615 (the “Company”), and the several purchasers identified in the attached Exhibit A (individually, a “Purchaser” and collectively, the
“Purchasers”). 
  
 WHEREAS, the Company desires
to issue and sell to the Purchasers an aggregate of approximately 2,800,000 shares (the “Shares”) of the authorized but unissued shares of common stock, $.001 par value per share, of the Company (the “Common
Stock”); and 
  
 WHEREAS, the Purchasers, severally,
wish to purchase the Shares on the terms and subject to the conditions set forth in this Agreement. 
  
 NOW THEREFORE, in consideration of the mutual agreements, representations, warranties and covenants herein contained, the parties hereto agree as follows:

  
 1. Definitions. As used in this Agreement, the
following terms shall have the following respective meanings: 
  
 (a) “Affiliate” of a party means any corporation or other business entity controlled by, controlling or under common control with such party. For this purpose “control” shall mean direct or indirect
beneficial ownership of fifty percent (50%) or more of the voting or income interest in such corporation or other business entity. 
  
 (b) “Closing Date” means the date of the Closing. 
  
 (c) “Exchange Act” means the Securities Exchange Act of 1934, as amended, and all of the rules and
regulations promulgated thereunder. 
  
 (d) “Registration
Rights Agreement” shall mean that certain Registration Rights Agreement, dated as of the date hereof, among the Company and the Purchasers. 
  
 (e) “Operative Agreements” shall mean the Registration Rights Agreement together with this Agreement. 
  
 (f) “Majority Purchasers” shall mean
Purchasers which, at any given time, hold greater than fifty percent (50%) of the voting power of the outstanding Shares that have not been resold pursuant to an effective registration statement under the Securities Act or Rule 144 under the
Securities Act. 
  
 (g) “SEC” shall mean the
Securities and Exchange Commission. 
  
 (h) “Securities
Act” shall mean the Securities Act of 1933, as amended, and all of the rules and regulations promulgated thereunder. 

 2. Purchase and Sale of Shares. 
  
 2.1 Purchase and Sale. Subject to and upon the terms and conditions set forth in this Agreement, the Company agrees
to issue and sell to each Purchaser, and each Purchaser, severally, hereby agrees to purchase from the Company, at the Closing, the number of shares of Common Stock set forth opposite the name of such Purchaser under the heading “Number of
Shares to be Purchased” on Exhibit A hereto, at a purchase price of $8.55 per share. The total purchase price payable by each Purchaser for the number of shares of Common Stock that such Purchaser is hereby agreeing to purchase is
set forth opposite the name of such Purchaser under the heading “Purchase Price” on Exhibit A hereto. The aggregate purchase price payable by the Purchasers to the Company for all of the Shares shall be $23,940,000.

  
 2.2 Closing. Upon confirmation that the other
conditions to closing specified herein have been satisfied or duly waived by the Purchasers, the Company shall deliver to the custodian designated by a Purchaser, in trust, a certificate or certificates, registered in such name or names as the
Purchasers may designate, representing the Shares, with instructions that such certificates are to be held for release to the Purchasers only upon payment in full of the Purchase Price to the Company by all the Purchasers. Upon (i) confirmation that
the conditions to closing specified under Section 5.1 have been satisfied or duly waived by the Purchasers and (ii) such receipt by such custodian of the certificates, each Purchaser shall, on the date of such receipt (provided such receipt is prior
to 1:00 p.m. Eastern time or such later time as a wire transfer reasonably can be initiated), cause a wire transfer in same day funds to be sent to the account of the Company as instructed in writing by the Company, in an amount representing such
Purchaser’s pro rata portion of the Purchase Price as set forth on the signature pages to this Agreement. On the date (the “Closing Date”) the Company receives the Purchase Price, the certificates evidencing the Shares shall be
released to the Purchasers (the “Closing”) 
  
 3.
Representations and Warranties of the Company. The Company hereby represents and warrants to each of the Purchasers as follows: 
  
 3.1 Incorporation. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and
is qualified to do business in each jurisdiction in which the character of its properties or the nature of its business requires such qualification, except where the failure to so qualify would not have a material adverse effect upon the Company.
The Company does not have any material subsidiaries other than those identified in the SEC Documents (as defined below). Except for short-term investments and investments that are not material to the Company, the Company does not own any shares of
stock or any other equity or long-term debt securities of any corporation or have any equity interest in any firm, partnership, limited liability company, joint venture, association or other entity except as set forth in the SEC Documents. Complete
and correct copies of the certificate of incorporation and bylaws of the Company as in effect on the Effective Date have been filed by the Company with the Commission. The Company has all requisite corporate power and authority to carry on its
business as now conducted. 
  
 3.2 Capitalization. The
authorized capital stock of the Company consists of (i) 50,000,000 shares of Common Stock, of which 26,857,107 shares are outstanding on the date hereof and (ii) 5,000,000 shares of preferred stock, of which no shares are outstanding on the 

  

 2 

 
date hereof. Except as set forth in Schedule 3.2 hereto, there are no existing options, warrants, calls, preemptive (or similar) rights, subscriptions
or other rights, agreements, arrangements or commitments of any character obligating the Company to issue, transfer or sell, or cause to be issued, transferred or sold, any shares of the capital stock of the Company or other equity interests in the
Company or any securities convertible into or exchangeable for such shares of capital stock or other equity interests, and there are no outstanding contractual obligations of the Company to repurchase, redeem or otherwise acquire any shares of its
capital stock or other equity interests. All of the issued and outstanding shares of the Company’s capital stock have been duly authorized and validly issued and are fully paid and nonassessable. 
  
 3.3 Authorization. All corporate action on the part of the Company,
its officers, directors and stockholders necessary for the authorization, execution, delivery and performance of this Agreement and the Registration Rights Agreement and the consummation of the transactions contemplated herein and therein has been
taken. When executed and delivered by the Company, each of this Agreement and the Registration Rights Agreement shall constitute the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms,
except as such may be limited by bankruptcy, insolvency, reorganization or other laws affecting creditors’ rights generally and by general equitable principles. The Company has all requisite corporate power to enter into this Agreement and the
Registration Rights Agreement and to carry out and perform its obligations under the terms of this Agreement, and the Registration Rights Agreement. 
  
 3.4 Valid Issuance of the Shares. The Shares being purchased by the Purchasers hereunder will, upon issuance pursuant to the terms hereof, be duly
authorized and validly issued, fully paid and nonassessable. No preemptive rights or other rights to subscribe for or purchase the Company’s capital stock exist with respect to the issuance and sale of the Shares by the Company pursuant to this
Agreement. Except as disclosed in the SEC Documents, no stockholder of the Company has any right (which has not been waived or has not expired by reason of lapse of time following the notification of the Company’s intent to file the
registration statement to be filed by the Company pursuant to Registration Rights Agreement (the “Registration Statement”) to require the Company to register the sale of any shares owned by such stockholder under the Securities Act
in the Registration Statement. As of the Effective Date, no further approval or authority of the stockholders or the Board of Directors of the Company shall be required for the issuance and sale of the Shares by the Company, or the filing of the
Registration Statement by the Company, as contemplated herein. 
  
 3.5 Financial Statements. The Company has furnished to each Purchaser its audited Statements of Income, Stockholders’ Equity and Cash Flows for the fiscal year ended December 31, 2004, its audited Balance Sheet as of December
31, 2004, its unaudited Statements of Income, Stockholders’ Equity and Cash Flows for the six months ended June 30, 2005 , and its unaudited Balance Sheet as of June 30, 2005. All such financial statements are hereinafter referred to
collectively as the “Financial Statements”. The Financial Statements have been prepared in accordance with generally accepted accounting principles applied on a consistent basis during the periods involved, and fairly present, in
all material respects, the financial position of the Company and the results of its operations as of the date and for the periods indicated thereon, except that the unaudited financial statements may not be in accordance with generally accepted
accounting principles because of the absence of footnotes normally contained 

  

 3 

 
therein and are subject to normal year-end audit adjustments. Since June 30, 2005, to the Company’s knowledge, there has been no material adverse change
(actual or threatened) in the assets, liabilities (contingent or other), affairs, operations, prospects or condition (financial or other) of the Company except as may be disclosed in the Company’s Quarterly Report on Form 10-Q for six months
ended June 30, 2005. 
  
 3.6 SEC Documents. The Company has
furnished to each Purchaser, a true and complete copy of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 (“Form 10-K”), the Company’s Quarterly Report on Form 10-Q for the six months
ended June 30, 2005 as filed with the SEC on August 9, 2005, and any other statement, report, registration statement (other than registration statements on Form S-8) or definitive proxy statement filed by the Company with the SEC during the period
commencing August 9, 2005 and ending on the date hereof. The Company will, promptly upon the filing thereof, also furnish to each Purchaser all statements, reports (including, without limitation, Quarterly Reports on Form 10-Q and Current Reports on
Form 8-K), registration statements and definitive proxy statements filed by the Company with the SEC during the period commencing on the date hereof and ending on the Closing Date (all such materials required to be furnished to each Purchaser
pursuant to this sentence or pursuant to the next preceding sentence of this Section 3.6 being called, collectively, the “SEC Documents”). As of their respective filing dates, the SEC Documents complied or will comply in all
material respects with the requirements of the Exchange Act or the Securities Act, as applicable, and none of the SEC Documents contained or will contain any untrue statement of a material fact or omitted or will omit to state a material fact
required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading, as of their respective filing dates, except to the extent corrected by a subsequently
filed SEC Document. True and complete copies of the Company’s certificate of incorporation and by-laws have been filed as exhibits to the SEC Documents. 
  
 3.7 Consents. All consents, approvals, orders and authorizations required on the part of the Company in connection with the execution, delivery or
performance of this Agreement and the Registration Rights Agreement and the consummation of the transactions contemplated herein and therein have been obtained and will be effective as of the Closing Date. 
  
 3.8 No Conflict. The execution and delivery of this Agreement and the
Registration Rights Agreement by the Company and the consummation of the transactions contemplated hereby and thereby will not conflict with or result in any violation of or default (with or without notice or lapse of time, or both) under, or give
rise to a right of termination, cancellation or acceleration of any obligation or to a loss of a material benefit under (i) any provision of the Certificate of Incorporation or By-laws of the Company or (ii) any agreement filed as an exhibit to the
Company’s Form 10-K and Forms 10-Q filed subsequent to Form 10-K, or any instrument, permit, franchise, license, judgment, order, statute, law, ordinance, rule or regulations, applicable to the Company or its respective properties or assets.

  
 3.9 Brokers or Finders. Except for Pacific Growth
Equities, Inc., the Company has not dealt with any broker or finder in connection with the transactions contemplated by this Agreement, and, except for certain fees and expenses payable by the Company to Pacific Growth Equities, Inc., the Company
has not incurred, and shall not incur, directly or indirectly, any liability for any brokerage or finders’ fees or agents commissions or any similar charges in connection with this Agreement or any transaction contemplated hereby. 

 

 4 

 3.10 Nasdaq National Market. The Common Stock is listed on the Nasdaq National Market System, and
there are no proceedings to revoke or suspend such listing. 
  
 3.11 Absence of Litigation. Except as disclosed in the SEC Documents, there is no action, suit or proceeding or, to the Company’s knowledge, any investigation, pending, or to the Company’s knowledge, threatened by or before
any governmental body against the Company and in which an unfavorable outcome, ruling or finding in any said matter, or for all matters taken as a whole, might have a material adverse effect on the Company. The foregoing includes, without
limitation, any such action, suit, proceeding or investigation that questions this Agreement or the Registration Rights Agreement or the right of the Company to execute, deliver and perform under same. 
  
 3.12 No Directed Selling Efforts or General Solicitation. Neither the
Company nor any person or entity acting on its behalf has conducted any general solicitation or general advertising (as those terms are used in Regulation D) in connection with the offer or sale of the Shares. 
  
 3.13 No Integrated Offering. Neither the Company nor any of its
Affiliates, nor any person or entity acting on its or their behalf has, directly or indirectly, made any offers or sales of any Company security or solicited any offers to buy any security, under circumstances that would adversely affect reliance by
the Company on Section 4(2) for the exemption from registration for the transactions contemplated hereby or would require registration of the Shares under the Securities Act. 
  
 3.14 Private Placement. The offer and sale of the Shares to the Purchasers as contemplated hereby is exempt from the
registration requirements of the Securities Act. 
  
 3.15
Questionable Payments. The Company has not, nor, to the knowledge of the Company’s Chief Executive Officer and Chief Financial Officer, has any of its current or former stockholders, directors, officers, employees, agents
or other Persons acting on behalf of the Company: (a) used any corporate funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity; (b) made any direct or indirect unlawful payments to any
governmental officials or employees from corporate funds; (c) established or maintained any unlawful or unrecorded fund of corporate monies or other assets; (d) made any false or fictitious entries on the books and records of the Company; or (e)
made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment of any nature. 
  
 3.16 Internal Controls. The Company is in material compliance with the provisions of the Sarbanes-Oxley Act of 2002 currently applicable to the
Company. The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are
recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization, and
(iv) the recorded 

  

 5 

 
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The
Company has established disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the Company and designed such disclosure controls and procedures to ensure that material information relating to the Company,
including its subsidiaries, is made known to the certifying officers by others within those entities, particularly during the period in which the Company’s most recently filed period report under the Exchange Act, as the case may be, is being
prepared. The Company’s certifying officers have evaluated the effectiveness of the Company’s controls and procedures as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the
“Evaluation Date”). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their
evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no significant changes in the Company’s internal controls (as such term is defined in Item 308 of Regulation S-K) or, to the knowledge of the Company’s Chief
Executive Officer or Chief Financial Officer, in other factors that could significantly affect the Company’s internal controls. The Company maintains and will continue to maintain a standard system of accounting established and administered in
accordance with GAAP and the applicable requirements of the Exchange Act. 
  
 3.17 Disclosures. Neither the Company nor any person or entity acting on its behalf has provided the Purchasers or their agents or counsel with any information that constitutes or might constitute material,
non-public information. The written materials delivered to the Purchasers in connection with the transactions contemplated by this Agreement do not contain any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements contained therein, in light of the circumstances under which they were made, not misleading. 
  
 4. Representations and Warranties of the Purchasers. Each Purchaser severally for itself, and not jointly with the other Purchasers, represents and
warrants to the Company as follows: 
  
 4.1 Authorization.
All action on the part of such Purchaser and, if applicable, its officers, directors and shareholders necessary for the authorization, execution, delivery and performance of this Agreement and the Registration Rights Agreement and the consummation
of the transactions contemplated herein and therein has been taken. When executed and delivered, each of this Agreement and the Registration Rights Agreement will constitute the legal, valid and binding obligation of such Purchaser, enforceable
against such Purchaser in accordance with its terms, except as such may be limited by bankruptcy, insolvency, reorganization or other laws affecting creditors’ rights generally and by general equitable principles. Such Purchaser has all
requisite corporate power to enter into each of this Agreement and the Registration Rights Agreement and to carry out and perform its obligations under the terms of this Agreement and the Registration Rights Agreement. Such Purchaser has the
knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Shares and has the ability to bear the economic risks of an investment in the Shares for an indefinite period of
time. The Purchaser acknowledges that the Placement Agent has made no representations or warranties regarding the Company; the Purchaser agrees that neither the Placement Agent nor any of its controlling persons, affiliates, directors, officers,

  

 6 

 
employees or consultants shall have any liability to the Purchaser or any person asserting claims on behalf of or in right of the Purchaser for any losses,
claims, damages, liabilities or expenses arising out of or relating to this Agreement or the Purchaser’s purchase of Shares. 
  
 4.2 Purchase Entirely for Own Account. Such Purchaser is acquiring the Shares being purchased by it hereunder for investment, for its own account,
and not for resale or with a view to distribution thereof in violation of the Securities Act. Such Purchaser has not entered into an agreement or understanding with any other party to resell or distribute such shares. 
  
 4.3 Investor Status; Etc. Such Purchaser certifies and represents to
the Company that at the time such Purchaser acquires any of the Shares, such Purchaser will be an “Accredited Investor” as defined in Rule 501 of Regulation D promulgated under the Securities Act and was not organized for the purpose of
acquiring the Shares. Such Purchaser’s financial condition is such that it is able to bear the risk of holding the Shares for an indefinite period of time and the risk of loss of its entire investment. Such Purchaser has been afforded the
opportunity to ask questions of and receive answers from the management of the Company concerning this investment and has sufficient knowledge and experience in investing in companies similar to the Company in terms of the Company’s stage of
development so as to be able to evaluate the risks and merits of its investment in the Company. 
  
 4.4 Confidential Information. Each Purchaser understands that any information provided to such Purchaser by the Company is strictly confidential
and proprietary to the Company and has been prepared from the Company’s publicly available documents and other information and is being submitted to the Purchaser solely for such Purchaser’s confidential use in connection with its
investment decision regarding the Shares. Such Purchaser agrees to use such information for the sole purpose of evaluating a possible investment in the Shares and such Purchaser hereby acknowledges that it is prohibited from reproducing or
distributing such information, the Operative Agreements, or any other offering materials, in whole or in part, or divulging or discussing any of their contents except for use internally and by its legal counsel and except as required by law or legal
process. Further, such Purchaser understands that the existence and nature of all conversations and presentations, if any, regarding the Company and this offering must be kept strictly confidential until such time as the Company makes public
announcement of the sale of Shares. Such Purchaser understands that the federal securities laws impose restrictions on trading based on information regarding this offering. In addition, such Purchaser hereby acknowledges that unauthorized public
disclosure of information regarding this offering may cause the Company to violate Regulation FD. Notwithstanding the foregoing, neither the Company nor any Person acting on its behalf has provided the Purchasers or their agents or counsel with any
information that constitutes or might constitute material, non-public information, and nothing contained in this Section 4.4 or in this Agreement shall be interpreted to the contrary. Moreover, the inclusion of this Section 4.4 herein shall not be
deemed an inference of any kind that any Purchaser is in possession of any confidential or proprietary or material non-public information of the Company. 
  
 4.5 Shares Not Registered. Such Purchaser understands that the Shares have not been registered under the Securities Act, by reason of their
issuance by the Company in a transaction exempt from the registration requirements of the Securities Act, and that the Shares must continue to be held by such Purchaser unless a subsequent disposition thereof is registered under 

  

 7 

 
the Securities Act or is exempt from such registration. The Purchaser understands that the exemptions from registration afforded by Rule 144 (the provisions
of which are known to it) promulgated under the Securities Act depend on the satisfaction of various conditions, and that, if applicable, Rule 144 may afford the basis for sales only in limited amounts. 
  
 4.6 No Conflict. The execution and delivery of this Agreement and the
Registration Rights Agreement by such Purchaser and the consummation of the transactions contemplated hereby and thereby will not conflict with or result in any violation of or default by such Purchaser (with or without notice or lapse of time, or
both) under, or give rise to a right of termination, cancellation or acceleration of any obligation or to a loss of a material benefit under (i) any provision of the organizational documents of such Purchaser or (ii) any agreement or instrument,
permit, franchise, license, judgment, order, statute, law, ordinance, rule or regulations, applicable to such Purchaser or its respective properties or assets. 
  

4.7 Brokers. Such Purchaser has not retained, utilized or been represented by any broker or finder in connection with the transactions
contemplated by this Agreement. 
  
 4.8 Consents. All
consents, approvals, orders and authorizations required on the part of such Purchaser in connection with the execution, delivery or performance of this Agreement and the consummation of the transactions contemplated herein have been obtained and are
effective as of the Closing Date. 
  
 4.9 No Intent to Effect a
Change of Control. Such Purchaser has no present intent to consummate a “change of control” of the Company, as such term is understood in Rule 13d of the Exchange Act. 
  
 4.10 No General Solicitation. Such Purchaser was not offered or sold the Shares, directly or indirectly, by means of
any form of general solicitation or general advertisement, including the following: (i) any advertisement, article, notice or other communication published in any newspaper, magazine or similar medium or broadcast over television, radio, the
internet or by telephone or (ii) any seminar or other meeting whose attendees had been invited by general solicitation or general advertising. 
  
 4.11 Prohibited Transactions. During the thirty (30) days prior to the date hereof, no Purchaser has, directly or indirectly, effected or agreed to
effect any short sale, whether or not against the box, established any “put equivalent position” (as defined in Rule 16a-1(h) under the 1934 Act) with respect to the Common Stock, granted any other right (including, without limitation, any
put or call option) with respect to the Common Stock or with respect to any security that includes, relates to or derived any significant part of its value from the Common Stock or otherwise sought to hedge its position in the Shares (each, a
“Prohibited Transaction”). Prior to the earlier of (i) the termination of this Agreement, or (ii) the effective date of the registration statement to be filed by the Company pursuant to the Registration Rights Agreement, no
Purchaser shall engage, directly or indirectly, in a Prohibited Transaction. Each Purchaser acknowledges that the representations and warranties contained in this Section 4.11 are being made for the benefit of the Purchasers as well as the Company
and that each of the other Purchasers shall have an independent the right to assert any claims against any Purchaser arising out of any breach or violation of the provisions of this Section 4.11. Without limiting the 

  

 8 

 
generality of the foregoing, each Purchaser understands and acknowledges that the SEC currently takes the position that coverage of short sales of shares of
the Common Stock “against the box” with the Shares purchased hereunder prior to the effective date of the Registration Statement is a violation of Section 5 of the Securities Act, as set forth in Item 65, Section 5 under Section A, of the
Manual of Publicly Available Telephone Interpretations, dated July 1997, compiled by the Office of Chief Counsel, Division of Corporation Finance. 
  
 5. Conditions Precedent. 
  
 5.1 Conditions to the Obligation of the Purchasers to Consummate the Closing. The obligation of each Purchaser to consummate the Closing and to
purchase and pay for the Shares being purchased by it pursuant to this Agreement is subject to the satisfaction of the following conditions precedent: 
  
 (a) The representations and warranties contained herein of the Company shall be true and correct on and as of the Closing Date with the same force and
effect as though made on and as of the Closing Date (it being understood and agreed by each Purchaser that, in the case of any representation and warranty of the Company contained herein which is not hereinabove qualified by application thereto of a
materiality standard, such representation and warranty need be true and correct only in all material respects in order to satisfy as to such representation or warranty the condition precedent set forth in the foregoing provisions of this Section
5.1(a)). 
  
 (b) The Registration Rights Agreement shall have been
executed and delivered by the Company. 
  
 (c) The Company shall
not have been adversely affected in any material way prior to the Closing Date; and the Company shall have performed all obligations and conditions herein required to be performed or observed by the Company on or prior to the Closing Date.

  
 (d) No proceeding challenging this Agreement or the
transactions contemplated hereby, or seeking to prohibit, alter, prevent or materially delay the Closing, shall have been instituted before any court, arbitrator or governmental body, agency or official and shall be pending. 
  
 (e) The purchase of and payment for the Shares by the Purchasers shall not be
prohibited by any law or governmental order or regulation. All necessary consents, approvals, licenses, permits, orders and authorizations of, or registrations, declarations and filings with, any governmental or administrative agency or of any other
person with respect to any of the transactions contemplated hereby shall have been duly obtained or made and shall be in full force and effect. 
  
 (f) All instruments and corporate proceedings in connection with the transactions contemplated by this Agreement to be consummated at the Closing shall be
satisfactory in form and substance to such Purchaser, and such Purchaser shall have received copies (executed or certified, as may be appropriate) of all documents which such Purchaser may have reasonably requested in connection with such
transactions. 
  

 9 

 (g) The Company shall have delivered a Certificate, executed on behalf of the Company by its Chief
Executive Officer or its Chief Financial Officer, dated as of the Closing Date, certifying to the fulfillment of the conditions specified in subsections (a), (b), and (c) of this Section 5.1 
  
 (h) The Purchasers shall have received an copy of and shall be entitled to
rely upon the opinion from the Company’s counsel to the Placement Agent, dated as of the Closing Date, in form and substance reasonably acceptable to the Purchasers. 
  
 5.2 Conditions to the Obligation of the Company to Consummate the Closing. The obligation of the Company to
consummate the Closing and to issue and sell to each of the Purchasers the Shares to be purchased by it at the Closing is subject to the satisfaction of the following conditions precedent: 
  
 (a) The representations and warranties contained herein of such Purchaser
shall be true and correct on and as of the Closing Date with the same force and effect as though made on and as of the Closing Date (it being understood and agreed by the Company that, in the case of any representation and warranty of each Purchaser
contained herein which is not hereinabove qualified by application thereto of a materiality standard, such representation and warranty need be true and correct only in all material respects in order to satisfy as to such representation or warranty
the condition precedent set forth in the foregoing provisions of this Section 5.2(a)). 
  
 (b) The Registration Rights Agreement shall have been executed and delivered by each Purchaser. 
  
 (c) The Purchasers shall have performed all obligations and conditions herein required to be performed or observed by the Purchasers on or prior to the
Closing Date. 
  
 (d) No proceeding challenging this Agreement or
the transactions contemplated hereby, or seeking to prohibit, alter, prevent or materially delay the Closing, shall have been instituted before any court, arbitrator or governmental body, agency or official and shall be pending. 
  
 (e) The sale of the Shares by the Company shall not be prohibited by any law
or governmental order or regulation. All necessary consents, approvals, licenses, permits, orders and authorizations of, or registrations, declarations and filings with, any governmental or administrative agency or of any other person with respect
to any of the transactions contemplated hereby shall have been duly obtained or made and shall be in full force and effect. 
  
 (f) Each of the Purchasers shall have executed and delivered to the Company a Purchaser’s Questionnaire, in the form attached hereto as Exhibit
B, pursuant to which each such Purchaser shall provide information necessary to confirm each such Purchaser’s status as an “accredited investor” (as such term is defined in Rule 501 promulgated under the Securities Act) and to
enable the Company to comply with the Registration Rights Agreement. 
  
 (g) Each of the other Purchasers shall have delivered the purchase price, in accordance with this Agreement, for the number of shares of Common Stock set forth opposite its name under the heading “Number of Shares to be
Purchased”. 
  

 10 

 (h) All instruments and corporate proceedings in connection with the transactions contemplated by this
Agreement to be consummated at the Closing shall be satisfactory in form and substance to the Company, and the Company shall have received counterpart originals, or certified or other copies of all documents, including without limitation records of
corporate or other proceedings, which it may have reasonably requested in connection therewith. 
  
 6. Covenants of the Company. 
  
 6.1 Listing of Underlying Shares and Related Matters. The Company shall apply to have the Shares included for listing on the Nasdaq National Market
and will take such other action as is necessary to cause the Shares to be so listed. The Company will use commercially reasonable efforts to continue the listing and trading of its Common Stock on such market or such other national exchange and will
use commercially reasonable efforts to comply in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules of such market or exchange, as applicable. 
  
 6.2 Removal of Legends. Upon the earlier of (a) registration for
resale pursuant to the Registration Rights Agreement and receipt by the Company of the Purchaser’s written confirmation that such Shares will not be disposed of except in compliance with the prospectus delivery requirements of the Securities
Act or (b) Rule 144(k) becoming available the Company shall, upon a Purchaser’s written request, promptly cause certificates evidencing the Purchaser’s Shares to be replaced with certificates which do not bear such restrictive legends.
When the Company is required to cause unlegended certificates to replace previously issued legended certificates, if unlegended certificates are not delivered to a Purchaser within three (3) Business Days of submission by that Purchaser of legended
certificate(s) to the Company’s transfer agent together with a representation letter in customary form, the Company shall be liable to the Purchaser for liquidated damages in an amount equal to 1.5% of the aggregate purchase price of the Shares
evidenced by such certificate(s) for each thirty (30) day period (or portion thereof) beyond such three (3) Business Day that the unlegended certificates have not been so delivered. 
  
 7. Transfer, Legends. 
  
 7.1 Securities Law Transfer Restrictions. 
  
 (a) Each Purchaser understands that, except as provided in the Registration Rights Agreement, the Shares have not been registered under the Securities Act
or any state securities laws, and each purchaser agrees that it will not sell, offer to sell, solicit offers to buy, dispose of, loan, pledge or grant any right with respect to (collectively, a “Disposition”), the Shares nor will
such Purchaser engage in any hedging or other transaction which is designed to or could be reasonably expected to lead to or result in a Disposition of Shares by such Purchaser or any other person or entity unless (a) the Shares are registered under
the Securities Act, or (b) such Purchaser shall have delivered to the Company an opinion of counsel in form, substance and scope reasonably acceptable to the Company, to the effect that registration is not required under the Securities Act or any
applicable state securities law due to the applicability of an exemption therefrom. In that connection, such Purchaser is aware of Rule 144 under the Securities Act and the restrictions imposed thereby. Such Purchaser acknowledges and agrees that no
sales of the Shares may be made under the Registration Statement and that the Shares are not transferable on 

  

 11 

 
the books of the Company unless the certificate submitted to the transfer agent evidencing the Shares is accompanied by a separate Purchaser’s
Certificate of Subsequent Sale: (i) in the form of Appendix I hereto; (ii) executed by an officer of, or other authorized person designated by, the Purchaser; and (iii) to the effect that (A) the shares have been sold in accordance with the
Registration Statement, the Securities Act and any applicable state securities or blue sky laws, and (B) the requirement of delivering a current prospectus has been satisfied. 
  
 (b) Each Purchaser represents and warrants that no action has been or will be taken in any jurisdiction outside the United
States by the Company or the Placement Agent that would permit an offering of the Shares, or possession or distribution of offering materials in connection with the issue of Shares, in any jurisdiction outside of the United States where action for
that purpose is required. Each Purchaser outside the United States will comply with all applicable laws and regulations in each foreign jurisdiction in which it purchases, offers, sells or delivers Shares or has in its possession or distributes any
offering material, in all cases at its own expense. The Placement Agent is not authorized to make any representation or use any information in connection with the issue, placement, purchase and sale of the Shares. 
  
 (c) Each Purchaser hereby covenants with the Company not to make any sale of
the Shares without complying with the provisions of the Operative Agreements, and such Purchaser acknowledges that the certificates evidencing the Shares will be imprinted with a legend that prohibits their transference except in accordance
therewith. Each Purchaser acknowledges that there may occasionally be times when the Company, based on the advice of its counsel, determines that it must suspend the Registration Statement, until such time as an amendment to the Registration
Statement has been filed by the Company and declared effective by the Commission or until the Company has amended or supplemented such Prospectus. 
  
 7.2 Legends. Each certificate requesting any of the Shares shall be endorsed with the legends set forth below, and each Purchaser covenants that,
except to the extent such restrictions are waived by the Company, it shall not transfer the shares represented by any such certificate without complying with the restrictions on transfer described in this Agreement and the legends endorsed on such
certificate: 
  
 “THE SHARES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM REGISTRATION UNDER SAID ACT AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM SAID ACT.” 
  
 8. Termination; Liabilities Consequent Thereon. This Agreement may be
terminated and the transactions contemplated hereunder abandoned at any time prior to the Closing only as follows: 
  
 (a) by the Purchasers, upon notice to the Company if the conditions set forth in Section 5.1 shall not have been satisfied on or prior to September 2,
2005; or 
  

 12 

 (b) by the Company, upon notice to the Purchasers if the conditions set forth in Section 5.2 shall not
have been satisfied on or prior to September 2, 2005; or 
  
 (c)
at any time by mutual agreement of the Company and the Purchasers; or 
  
 (d) by the Purchasers, if there has been any breach of any representation or warranty or any material breach of any covenant of the Company contained herein and the same has not been cured within 15 days after notice thereof, (it being
understood and agreed by each Purchaser that, in the case of any representation or warranty of the Company contained herein which is not hereinabove qualified by application thereto of a materiality standard, such representation or warranty will be
deemed to have been breached for purposes of this Section 8(d) only if such representation or warranty was not true and correct in all material respects at the time such representation or warranty was made by the Company); or 
  
 (e) by the Company, if there has been any breach of any representation,
warranty or any material breach of any covenant of any Purchaser contained herein and the same has not been cured within 15 days after notice thereof (it being understood and agreed by the Company that, in the case of any representation and warranty
of the Purchaser contained herein which is not hereinabove qualified by application thereto of a materiality standard, such representation or warranty will be deemed to have been breached for purposes of this Section 8(e) only if such representation
or warranty was not true and correct in all material respects at the time such representation or warranty was made by such Purchaser). 
  
 Any termination pursuant to this Section 8 shall be without liability on the part of any party, unless such termination is the result of a material breach
of this Agreement by a party to this Agreement in which case such breaching party shall remain liable for such breach notwithstanding any termination of this Agreement. 
  
 9. Miscellaneous Provisions. 
  
 9.1 Public Statements or Releases. The Company shall, by 8:30 a.m. Eastern time on the business day following the
Closing Date, file a Current Report on Form 8-K, disclosing the transactions contemplated hereby and make such other filings and notices in the manner and time required by the SEC. The Company and each Purchaser shall consult with each other in
issuing any press releases with respect to the transactions contemplated hereby, and none of the parties to this Agreement shall issue any such press release or other public announcement, without the prior consent of the other parties, which shall
not be unreasonably withheld or delayed, provided, that nothing in this Section 9.1 shall prevent any of the parties hereto from making such public announcements as it may consider necessary in order to satisfy its legal obligations, but to
the extent not inconsistent with such obligations, it shall provide the other parties with an opportunity to review and comment on any proposed public announcement before it is made. 
  
 9.2 Further Assurances. Each party agrees to cooperate fully with the other party and to execute such further
instruments, documents and agreements and to give such further written assurances, as may be reasonably requested by the other party to better evidence and reflect the transactions described herein and contemplated hereby, and to carry into effect
the intents and purposes of this Agreement. 
  

 13 

 9.3 Rights Cumulative. Each and all of the various rights, powers and remedies of the parties
shall be considered to be cumulative with and in addition to any other rights, powers and remedies which such parties may have at law or in equity in the event of the breach of any of the terms of this Agreement. The exercise or partial exercise of
any right, power or remedy shall neither constitute the exclusive election thereof nor the waiver of any other right, power or remedy available to such party. 
  

9.4 Pronouns. All pronouns or any variation thereof shall be deemed to refer to the masculine, feminine or neuter, singular or plural, as the
identity of the person, persons, entity or entities may require. 
  
 9.5 Notices. 
  
 (a) Any notices, reports or
other correspondence (hereinafter collectively referred to as “correspondence”) required or permitted to be given hereunder shall be sent by postage prepaid first class mail, courier or telecopy or delivered by hand to the party to
whom such correspondence is required or permitted to be given hereunder. The date of giving any notice shall be the date of its actual receipt. 
  
 (b) All correspondence to the Company shall be addressed as follows: 
  
 Regeneration Technologies, Inc. 
 11621 Research Circle 
 Alachua, Florida 32615 
 Attn: Brian K. Hutchison 
 President and Chief Executive Officer 
 Telecopier: 386-418-3608 
  
 with a copy (which shall not constitute notice) to: 
  
 Fulbright & Jaworski L.L.P 
 666 Fifth Avenue 
 New York, New York 10103 
 Attn: Warren J. Nimetz, Esq. 
 Telecopier: 212-318-3400 
  
 (c)
All correspondence to any Purchaser shall be sent to such Purchaser at the address set forth in Exhibit A. 
  
 (d) Any entity may change the address to which correspondence to it is to be addressed by notification as provided for herein. 
  
 9.6 Captions. The captions and paragraph headings of this Agreement
are solely for the convenience of reference and shall not affect its interpretation. 
  

 14 

 9.7 Severability. Should any part or provision of this Agreement be held unenforceable or in
conflict with the applicable laws or regulations of any jurisdiction, the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent possible, the original business purpose of such part or
provision in a valid and enforceable manner, and the remainder of this Agreement shall remain binding upon the parties hereto. 
  
 9.8 Governing Law; Consent to Jurisdiction; Injunctive Relief. 
  
 (a) This Agreement shall be governed by and construed in accordance with the internal and substantive laws of State of New
York and without regard to any conflicts of laws concepts which would apply the substantive law of some other jurisdiction. 
  
 (b) Each of the parties hereto irrevocably submits to the exclusive jurisdiction of the courts of the State of New York located in New York County and the
United States District Court for the Southern District of New York for the purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement and the transactions contemplated hereby. Service of process in connection
with any such suit, action or proceeding may be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices under this Agreement. Each of the parties hereto irrevocably consents to the
jurisdiction of any such court in any such suit, action or proceeding and to the laying of venue in such court. Each party hereto irrevocably waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts
and irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. 
  
 (c) Each of the parties hereto acknowledges and agrees that damages will not be an adequate remedy for any material breach or violation of this Agreement
if such material breach or violation would cause immediate and irreparable harm (an “Irreparable Breach”). Accordingly, in the event of a threatened or ongoing Irreparable Breach, each party hereto shall be entitled to seek, in the
courts of the State of New York located in New York County and the United States District Court for the Southern District of New York, equitable relief of a kind appropriate in light of the nature of the ongoing or threatened Irreparable Breach,
which relief may include, without limitation, specific performance or injunctive relief; provided, however, that if the party bringing such action is unsuccessful in obtaining the relief sought, the moving party shall pay the
non-moving party’s reasonable costs, including attorney’s fees, incurred in connection with defending such action. Such remedies shall not be the parties’ exclusive remedies, but shall be in addition to all other remedies provided in
this Agreement. 
  
 9.9 Waiver. No waiver of any term,
provision or condition of this Agreement, whether by conduct or otherwise, in any one or more instances, shall be deemed to be, or be construed as, a further or continuing waiver of any such term, provision or condition or as a waiver of any other
term, provision or condition of this Agreement. 
  
 9.10
Expenses. Each party will bear its own costs and expenses in connection with this Agreement. 
  

 15 

 9.11 Assignment. The rights and obligations of the parties hereto shall inure to the benefit of
and shall be binding upon the authorized successors and permitted assigns of each party. Neither party may assign its rights or obligations under this Agreement or designate another person (i) to perform all or part of its obligations under this
Agreement or (ii) to have all or part of its rights and benefits under this Agreement, in each case without the prior written consent of the other party. In the event of any assignment in accordance with the terms of this Agreement, the assignee
shall specifically assume and be bound by the provisions of the Agreement by executing and agreeing to an assumption agreement reasonably acceptable to the other party. 
  
 9.12 Survival. The respective representations and warranties given by the parties hereto, and the other covenants and
agreements contained herein, shall survive the Closing Date and the consummation of the transactions contemplated herein for a period of two years, without regard to any investigation made by any party. 
  
 9.13 Entire Agreement. This Agreement constitutes the entire agreement
between the parties hereto respecting the subject matter hereof and supersedes all prior agreements, negotiations, understandings, representations and statements respecting the subject matter hereof, whether written or oral. No modification,
alteration, waiver or change in any of the terms of this Agreement shall be valid or binding upon the parties hereto unless made in writing and duly executed by the Company and the Majority Purchasers. 
  

 16 

 IN WITNESS WHEREOF, the parties hereto have executed this Stock Purchase Agreement under seal as of the
day and year first above written. 
  

			
	REGENERATION TECHNOLOGIES, INC.
		
	By:	 	 /s/ Brian K. Hutchison

	Name:	 	Brian K. Hutchison
	Title:	 	Chairman, President and Chief Executive Officer

  
 THE PURCHASER’S
SIGNATURE TO THE INVESTOR QUESTIONNAIRE DATED EVEN DATE HEREWITH SHALL CONSTITUTE THE PURCHASER’S SIGNATURE TO THIS STOCK PURCHASE AGREEMENT. 
  

 17 

 Exhibit A 
  
 PURCHASERS 
  

			
	 Purchaser

	  	Number of Shares
to be Purchased

	 OFIL PLC U.S. Emerging Growth Fund Register in nominee name: Kane & Co.
	  	7,300
	 USAZ Oppenheimer Emerging Growth Fund Register in nominee name: Booth & Co.
	  	96,400
	 Oppenheimer Discovery Fund Register in nominee name: Gerlach & Co.
	  	666,900
	 Oppenheimer Emerging Growth Fund Register in nominee name: Gerlach & Co.
	  	79,400
	 Henry C. Beinstein
	  	23,392
	 Upland Associates L.P.
	  	46,783
	 Neil J. Gagnon
	  	152,047
	 Lois E. Gagnon
	  	101,403
	 The Lois E. and Neil J. Gagnon Foundation
	  	40,935
	 Gagnon Family Partnership
	  	29,240
	 Gagnon Investment Associates
	  	116,960
	 Gagnon 1999 Grandchildren’s Trust STS 2/1/99 Maureen Drew, TTEE
	  	29,240
	 Zeke L.P.
	  	300,000
	 MedCap Partners L.P.
	  	300,000
	 MedCap Master Fund L.P.
	  	50,000
	 Capital Ventures International
	  	160,000
	 Special Situation Cayman Fund L.P.
	  	120,000
	 Special Situation Fund III L.P.
	  	480,000
	 	  	

	 Total:
	  	2,800,000
	 	  	

  

 18 

 Appendix I 
  
 REGENERATION TECHNOLOGIES, INC. 
 PURCHASER’S CERTIFICATE OF SUBSEQUENT SALE 
  

			
	 Attention:
	  	Regeneration Technologies, Inc.
	 	  	Chief Financial Officer

  
 The undersigned, [an
officer of, or other person duly authorized by]                      [fill in official name of individual or institution] hereby certifies
that he/she [said institution] is the Purchaser of the Shares evidenced by the attached certificate, and as such, sold such shares on
                     in accordance with [date] Registration Statement
number                     [fill in the number of or otherwise identify Registration Statement] and the requirement of delivering a current
prospectus by the Company has been complied with in connection with such sale. 
  

			
	 Print or Type:
	  	 
		
	 Name of Purchaser
	  	 
	 (Individual or Institution):
	  	  

		
	 Name of Individual
	  	 
	 Representing Purchaser
	  	 
	 (if an institution):
	  	  

		
	 Title of Individual
	  	 
	 Representing Purchaser
	  	 
	 (if an institution):
	  	  

		
	 Signature by:
	  	 
		
	 Individual Purchaser
	  	 
	 or Individual representing
	  	 
	 Purchaser:
	  	  

  

 19Registration Rights Agreement

 EXHIBIT 10.2 
  
 EXECUTION COPY 
  
 REGISTRATION RIGHTS AGREEMENT 
  
 This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of August 24, 2005, by and among (i) REGENERATION TECHNOLOGIES, INC., a
Delaware corporation (the “Company”), (ii) each person listed on Exhibit A attached hereto (collectively, the “Initial Investors” and each individually, an “Initial Investor”), and
(iii) each person or entity that subsequently becomes a party to this Agreement pursuant to, and in accordance with, the provisions of Section 12 hereof (collectively, the “Investor Permitted Transferees” and each individually an
“Investor Permitted Transferee”). 
  
 WHEREAS,
the Company has agreed to issue and sell to the Initial Investors, and the Initial Investors have agreed to purchase from the Company, 2,800,000 shares (the “Purchased Shares”) of the Company’s common stock, $0.001 par value
per share (the “Common Stock”), all upon the terms and conditions set forth in that certain Stock Purchase Agreement, dated of even date herewith, between the Company and the Initial Investors (the “Stock Purchase
Agreement”); and 
  
 WHEREAS, the terms of the Stock
Purchase Agreement provide that it shall be a condition precedent to the closing of the transactions thereunder, for the Company and the Initial Investors to execute and deliver this Agreement. 
  
 NOW, THEREFORE, in consideration of the premises and mutual covenants
contained herein, the parties hereto hereby agree as follows: 
  
 1. DEFINITIONS. The following terms shall have the meanings provided therefor below or elsewhere in this Agreement as described below: 
  
 “Board” shall mean the board of directors of the Company. 
  
 “Business Day” means a day, other than a Saturday or Sunday, on which banks in New York City are open for
the general transaction of business. 
  
 “Closing” and “Closing Date” shall have the meanings ascribed to such terms in the Stock Purchase Agreement. 
  
 “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and all of the rules and regulations promulgated
thereunder. 
  
 “Investors” shall mean,
collectively, the Initial Investors and the Investor Permitted Transferees; provided, however, that the term “Investors” shall not include any of the Initial Investors or any of the Investor Permitted Transferees that
ceases to own or hold any Purchased Shares. 
  
 “Majority
Holders” shall mean, at the relevant time of reference thereto, those Investors holding more than fifty percent (50%) of the Registrable Shares held by all of the Investors. 
  
 “Qualifying Holder” shall have the meaning ascribed thereto in Section 12 hereof. 

 “Registrable Shares” shall mean the Purchased Shares, provided, however,
such term shall not, after the Mandatory Registration Termination Date, include any of the Purchased Shares that become or have become eligible for resale pursuant to Rule 144 or pursuant to Regulation S. 
  
 “Rule 144” shall mean Rule 144 promulgated under the
Securities Act and any successor or substitute rule, law or provision. 
  
 “SEC” shall mean the Securities and Exchange Commission. 
  
 “Securities Act” shall mean the Securities Act of 1933, as amended, and all of the rules and regulations promulgated thereunder. 
  
 2. EFFECTIVENESS; TERMINATION. This Agreement shall become effective and legally binding only if the Closing occurs.
This Agreement shall terminate and be of no further force or effect, automatically and without any action being required of any party hereto, upon the termination of the Stock Purchase Agreement pursuant to Section 8 thereof. 
  
 3. MANDATORY REGISTRATION. 
  
 (a) Within thirty (30) days after the Closing, the Company will prepare and
file with the SEC a registration statement on Form S-3, or any other eligible form if the Company is not eligible to use Form S-3, for the purpose of registering under the Securities Act all of the Registrable Shares for resale by, and for the
account of, the Investors as selling stockholders thereunder (the “Registration Statement”). The Registration Statement shall permit the Investors to offer and sell, on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act, any or all of the Registrable Shares. 
  
 (b) The
Company agrees to use its reasonable best efforts to cause the Registration Statement to become effective as soon as practicable. If (i) a Registration Statement covering the Registrable Shares is not declared effective by the SEC within ninety (90)
days after the Closing Date or (ii) after a Registration Statement has been declared effective by the SEC, sales cannot be made pursuant to such Registration Statement (including without limitation by reason of a stop order, or the Company’s
failure to update the Registration Statement), but excluding the inability of any Investor to sell the Registrable Shares covered thereby due to market conditions and excluding any Suspension Period (as defined below), then the Company will make pro
rata payments to each Investor, as liquidated damages and not as a penalty, in an amount equal to 1% of the aggregate amount invested by such Investor for each 30-day period or pro rata for any portion thereof following the date by which such
Registration Statement should have been effective; provided, however, that in no event shall the Company be obligated to pay such liquidated damages to more than one Investor in respect of the same Registrable Shares for the same
period of time. Each Investor shall cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of a Registration Statement hereunder, including without limitation by furnishing in writing to the
Company such information regarding itself, the Registrable Shares held by it and the intended method of disposition of the Registrable Shares held by it, as shall be reasonably required to effect the registration of such Registrable Securities and
by executing such documents in connection with such registration as the Company may reasonably request. The Company shall have no obligation to make liquidated damages payments under this Section 3(b) to any Investor that is in breach of these
obligations. 
  

 2 

 (c) The Company shall be required to keep the Registration Statement effective until such date that is
the earlier of (i) the date as of which all of the Purchasers may sell all of the Registrable Securities without restriction pursuant to Rule 144(k) (or the successor rule thereto) (but not earlier than the second anniversary of the Closing Date,
subject to extension as set forth below) promulgated under the Securities Act or (ii) the date when all of the Registrable Shares registered thereunder shall have been sold (such date is referred to herein as the “Mandatory Registration
Termination Date”). Thereafter, the Company shall be entitled to withdraw the Registration Statement and the Investors shall have no further right to offer or sell any of the Registrable Shares pursuant to the Registration Statement (or any
prospectus relating thereto). In the event the right of the selling Investors to use the Registration Statement (and the prospectus relating thereto) is delayed or suspended pursuant to Sections 5(c) or 11 hereof, the Company shall be required to
extend the Mandatory Registration Termination Date beyond the second anniversary of the Closing Date by the same number of days as such delay or Suspension Period (as defined in Section 11 hereof). 
  
 (d) The offer and sale of the Registrable Shares pursuant to the Registration
Statement shall not be underwritten. 
  
 4.
“PIGGYBACK” REGISTRATION RIGHTS. 
  
 (a) If, at
any time after the Mandatory Registration Termination Date, the Company proposes to register any of its Common Stock under the Securities Act, whether as a result of a primary or secondary offering of Common Stock or pursuant to registration rights
granted to holders of other securities of the Company (but excluding in all cases any registrations to be effected on Forms S-4 or S-8 or other applicable successor Forms), the Company shall, each such time, give to the Investors holding Registrable
Shares written notice of its intent to do so. Upon the written request of any such Investor given within 20 days after the giving of any such notice by the Company, the Company shall use its reasonable best efforts to cause to be included in such
registration the Registrable Shares of such selling Investor, to the extent requested to be registered; provided that (i) the number of Registrable Shares proposed to be sold by such selling Investor is equal to at least seventy-five percent
(75%) of the total number of Registrable Shares then held by such participating selling Investor, (ii) such selling Investor agrees to sell those of its Registrable Shares to be included in such registration in the same manner and on the same terms
and conditions as the other shares of Common Stock which the Company proposes to register, and (iii) if the registration is to include shares of Common Stock to be sold for the account of the Company or any party exercising demand registration
rights pursuant to any other agreement with the Company, the proposed managing underwriter does not advise the Company that in its opinion the inclusion of such selling Investor’s Registrable Shares (without any reduction in the number of
shares to be sold for the account of the Company or such party exercising demand registration rights) is likely to affect materially and adversely the success of the offering or the price that would be received for any shares of Common Stock
offered, in which case the rights of such selling Investor shall be as provided in Section 4(b) hereof. 
  
 (b) If a registration pursuant to Section 4(a) hereof involves an underwritten offering and the managing underwriter shall advise the Company in writing
that, in its opinion, the number of 

  

 3 

 
shares of Common Stock requested by the Investors to be included in such registration is likely to affect materially and adversely the success of the
offering or the price that would be received for any shares of Common Stock offered in such offering, then, notwithstanding anything in Section 4(a) to the contrary, the Company shall only be required to include in such registration, to the extent
of the number of shares of Common Stock which the Company is so advised can be sold in such offering, (i) first, the number of shares of Common Stock proposed to be included in such registration for the account of the Company and/or any stockholders
of the Company (other than the Investors) that have exercised demand registration rights, in accordance with the priorities, if any, then existing among the Company and/or such stockholders of the Company with registration rights (other than the
Investors), and (ii) second, the shares of Common Stock requested to be included in such registration by all other stockholders of the Company who have piggyback registration rights (including, without limitation, the Investors), pro
rata among such other stockholders (including, without limitation, the Investors) on the basis of the number of shares of Common Stock that each of them requested to be included in such registration. 
  
 (c) In connection with any offering involving an underwriting of shares, the
Company shall not be required under Section 4 hereof or otherwise to include the Registrable Shares of any Investor therein unless such Investor accepts and agrees to the terms of the underwriting as agreed upon between the Company and the
underwriters selected by the Company. 
  
 5. OBLIGATIONS OF THE
COMPANY. In connection with the Company’s obligation under Section 3 and 4 hereof to file the Registration Statement with the SEC and to use its reasonable best efforts to cause the Registration Statement to become effective as soon as
practicable, the Company shall, as expeditiously as reasonably possible: 
  
 (a) Prepare and file with the SEC such amendments and supplements to the Registration Statement and the prospectus used in connection therewith as may be necessary to comply with the provisions of the Securities Act
with respect to the disposition of all Registrable Shares covered by the Registration Statement; 
  
 (b) furnish to the Purchasers and their legal counsel (i) promptly after the same is prepared and publicly distributed, filed with the SEC, or received by
the Company (but not later than two (2) Business Days after the filing date, receipt date or sending date, as the case may be) one (1) copy of the Registration Statement and any amendment thereto, each preliminary prospectus and prospectus relating
thereto and each amendment or supplement thereto, and each letter written by or on behalf of the Company to the SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC, in each case relating to the
Registration Statement (other than any portion of any thereof which contains information for which the Company has sought confidential treatment), and (ii) such number of copies of a prospectus, including a preliminary prospectus, and all amendments
and supplements thereto and such other documents as each Purchaser may reasonably request in order to facilitate the disposition of the Registrable Shares owned by such Purchaser that are covered by the Registration Statement; 
  
 (c) Notify the selling Investors, at any time when a prospectus relating to
the Registration Statement is required to be delivered under the Securities Act, of the happening of any event as a result of which the prospectus included in or relating to the Registration Statement contains an untrue statement of a material fact
or omits any fact necessary to make the statements therein not 

  

 4 

 
misleading; and, thereafter, the Company will promptly prepare (and, when completed, give notice to each selling Investor) a supplement or amendment to such
prospectus so that, as thereafter delivered to the purchasers of such Registrable Shares, such prospectus will not contain an untrue statement of a material fact or omit to state any fact necessary to make the statements therein not misleading;
provided that upon such notification by the Company, the selling Investors will not offer or sell Registrable Shares until the Company has notified the selling Investors that it has prepared a supplement or amendment to such prospectus and
delivered copies of such supplement or amendment to the selling Investors (it being understood and agreed by the Company that the foregoing proviso shall in no way diminish or otherwise impair the Company’s obligation to promptly prepare a
prospectus amendment or supplement as above provided in this Section 5(c) and deliver copies of same as above provided in Section 5(b) hereof); 
  
 (d) Use its reasonable best efforts to register and qualify the Registrable Shares covered by the Registration Statement under such other securities or
Blue Sky laws of such jurisdictions as shall be reasonably appropriate in the opinion of the Company and the managing underwriters, if any, provided that the Company shall not be required in connection therewith or as a condition thereto to
qualify to do business or to file a general consent to service of process in any such states or jurisdictions, and provided further that (notwithstanding anything in this Agreement to the contrary with respect to the bearing of
expenses) if any jurisdiction in which any of such Registrable Shares shall be qualified shall require that expenses incurred in connection with the qualification therein of any such Registrable Shares be borne by the selling Investors, then the
selling Investors shall, to the extent required by such jurisdiction, pay their pro rata share of such qualification expenses; 
  
 (e) Subject to the terms and conditions of this Agreement, including Section 4 hereof, use its reasonable best efforts to (i) prevent the issuance of any
stop order or other suspension of effectiveness of a Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction in the United States, (ii) if such an order or suspension is
issued, obtain the withdrawal of such order or suspension at the earliest practicable moment and notify each holder of Registrable Securities of the issuance of such order and the resolution thereof or its receipt of notice of the initiation or
threat of any proceeding such purpose; 
  
 (f) (i) Timely notify
the Nasdaq National Market of the issuance of the Shares and (ii) engage a transfer agent and registrar to maintain the Company’s stock ledger for all Shares covered by the Registration Statement not later than the effective date of the
Registration Statement;. 
  
 (g) Provide copies to and permit
counsel designated by the Purchasers to review the Registration Statement and all amendments and supplements thereto no fewer than two Business Days prior to their filing with the SEC and to consult with such counsel with respect to any document to
which such counsel objects; and 
  
 (h) Use commercially
reasonable efforts to cause all Registrable Shares covered by the Registration Statement to be listed on each securities exchange, interdealer quotation system or other market on which similar securities issued by the Company are then listed.

  
 6. FURNISH INFORMATION. It shall be a condition
precedent to the obligations of the Company to take any action pursuant to this Agreement that the selling Investors shall furnish to the Company such information regarding them and the securities held by them as the Company shall 

  

 5 

 
reasonably request and as shall be required in order to effect any registration by the Company pursuant to this Agreement. Each Investor shall promptly
notify the Company of any changes in the information furnished by the Company. 
  
 7. EXPENSES OF REGISTRATION. Except as set forth in Section 5(d), all expenses incurred in connection with the registration of the Registrable Shares pursuant to this Agreement (excluding underwriting,
brokerage and other selling commissions and discounts), including without limitation all registration and qualification and filing fees, printing, and fees and disbursements of counsel for the Company, shall be borne by the Company. 
  
 8. DELAY OF REGISTRATION. The Investors shall not take any action to
restrain, enjoin or otherwise delay any registration as the result of any controversy which might arise with respect to the interpretation or implementation of this Agreement. 
  
 9. INDEMNIFICATION. 
  
 (a) To the extent permitted by law, the Company will indemnify and hold harmless each selling Investor, any investment banking firm acting as an
underwriter for the selling Investors, any broker/dealer acting on behalf of any selling Investors and each officer and director of such selling Investor, such underwriter, such broker/dealer and each person, if any, who controls such selling
Investor, such underwriter or broker/dealer within the meaning of the Securities Act, against any losses, claims, damages or liabilities, joint or several, to which they may become subject under the Securities Act or otherwise, insofar as such
losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue or alleged untrue statement of any material fact contained in the Registration Statement, in any preliminary prospectus or final
prospectus relating thereto or in any amendments or supplements to the Registration Statement or any such preliminary prospectus or final prospectus, or arise out of or are based upon the omission or alleged omission to state therein a material fact
required to be stated therein, or necessary to make the statements therein not misleading; and will reimburse such selling Investor, such underwriter, broker/dealer or such officer, director or controlling person for any legal or other expenses
reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained in this Section 9(a) shall not apply to amounts paid
in settlement of any such loss, claim, damage, liability or action if (i) such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), (ii) it arises out of or is based upon an untrue statement
or alleged untrue statement or omission made in connection with the Registration Statement, any preliminary prospectus or final prospectus relating thereto or any amendments or supplements to the Registration Statement or any such preliminary
prospectus or final prospectus, in reliance upon and in conformity with written information furnished expressly for use in connection with the Registration Statement or any such preliminary prospectus or final prospectus by the selling Investors,
any underwriter for them or controlling person with respect to them or (iii) it arises out of the use by the selling Investors of an outdated or defective prospectus after the Company has notified such Investor in writing that the prospectus is
outdated or defective and prior to the receipt by such Investor of the written advice from the Company that the use of the prospectus may be resumed. 
  
 (b) To the extent permitted by law, each selling Investor will severally and not jointly indemnify and hold harmless the Company, each of its directors,
each of its officers who have signed 

  

 6 

 
the Registration Statement, each person, if any, who controls the Company within the meaning of the Securities Act, any investment banking firm acting as
underwriter for the Company or the selling Investors, or any broker/dealer acting on behalf of the Company or any selling Investors, and all other selling Investors against any losses, claims, damages or liabilities to which the Company or any such
director, officer, controlling person, underwriter, or broker/dealer or such other selling Investor may become subject to, under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereto)
arise out of or are based upon any untrue or alleged untrue statement of any material fact contained in the Registration Statement or any preliminary prospectus or final prospectus, relating thereto or in any amendments or supplements to the
Registration Statement or any such preliminary prospectus or final prospectus, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements
therein not misleading, in each case to the extent and only to the extent that such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement, in any preliminary prospectus or final
prospectus relating thereto or in any amendments or supplements to the Registration Statement or any such preliminary prospectus or final prospectus, in reliance upon and in conformity with written information furnished by the selling Investor
expressly for use in connection with the Registration Statement, or any preliminary prospectus or final prospectus; and such selling Investor will reimburse any legal or other expenses reasonably incurred by the Company or any such director,
officer, controlling person, underwriter, broker/dealer or other selling Investor in connection with investigating or defending any such loss, claim, damage, liability or action, provided, however, that the liability of each selling
Investor hereunder shall be limited to the proceeds (net of underwriting discounts and commissions, if any) received by such selling Investor from the sale of Registrable Shares covered by the Registration Statement, and provided,
further, however, that the indemnity agreement contained in this Section 9(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of
those selling Investor(s) against which the request for indemnity is being made (which consent shall not be unreasonably withheld). 
  
 (c) Promptly after receipt by an indemnified party under this Section 9 of notice of the commencement of any action, such indemnified party will, if a
claim in respect thereof is to be made against any indemnifying party under this Section 9, notify the indemnifying party in writing of the commencement thereof and the indemnifying party shall have the right to participate in and, to the extent the
indemnifying party desires, jointly with any other indemnifying party similarly noticed, to assume at its expense the defense thereof with counsel mutually satisfactory to the indemnifying parties with the consent of the indemnified party which
consent will not be unreasonably withheld, conditioned or delayed. In the event that the indemnifying party assumes any such defense, the indemnified party may participate in such defense with its own counsel and at its own expense, provided,
however, that the counsel for the indemnifying party shall act as lead counsel in all matters pertaining to such defense or settlement of such claim and the indemnifying party shall only pay for such indemnified party’s expenses for the
period prior to the date of its participation on such defense. The failure to notify an indemnifying party promptly of the commencement of any such action, if prejudicial to his ability to defend such action, shall relieve such indemnifying party of
any liability to the indemnified party under this Section 9, but the omission so to notify the indemnifying party will not relieve him of any liability which he may have to any indemnified party otherwise other than under this Section 9. 

 

 7 

 (d) Notwithstanding anything to the contrary herein, the indemnifying party shall not be entitled to
settle any claim, suit or proceeding unless in connection with such settlement the indemnified party receives an unconditional release with respect to the subject matter of such claim, suit or proceeding and such settlement does not contain any
admission of fault by the indemnified party. 
  
 10. REPORTS
UNDER THE EXCHANGE ACT. With a view to making available to the Investors the benefits of Rule 144 and any other rule or regulation of the SEC that may at any time permit the Investors to sell the Purchased Shares to the public without
registration, the Company agrees to use its reasonable best efforts: (i) to make and keep public information available, as those terms are understood and defined in the General Instructions to Form S-3, or any successor or substitute form, and in
Rule 144, (ii) to file with the SEC in a timely manner all reports and other documents required to be filed by an issuer of securities registered under the Securities Act or the Exchange Act, (iii) as long as any Investor owns any Purchased Shares,
to furnish in writing upon such Investor’s request a written statement by the Company that it has complied with the reporting requirements of Rule 144 and of the Securities Act and the Exchange Act, and to furnish to such Investor a copy of the
most recent annual or quarterly report of the Company, and such other reports and documents so filed by the Company as may be reasonably requested in availing such Investor of any rule or regulation of the SEC permitting the selling of any such
Purchased Shares without registration and (iv) undertake any additional actions reasonably necessary to maintain the availability of the Registration Statement or the use of Rule 144. 
  
 11. DEFERRAL AND LOCK-UP. 
  

(a) Notwithstanding anything in this Agreement to the contrary, if the Company shall furnish to the selling Investors a certificate signed by the
President or Chief Executive Officer of the Company stating that the Board of Directors of the Company has made the good faith determination (i) that continued use by the selling Investors of the Registration Statement for purposes of effecting
offers or sales of Registrable Shares pursuant thereto would require, under the Securities Act, premature disclosure in the Registration Statement (or the prospectus relating thereto) of material, nonpublic information concerning the Company, its
business or prospects or any proposed material transaction involving the Company, (ii) that such premature disclosure would be materially adverse to the Company, its business or prospects or any such proposed material transaction or would make the
successful consummation by the Company of any such material transaction significantly less likely and (iii) that it is therefore essential to suspend the use by the Investors of such Registration Statement (and the prospectus relating thereto) for
purposes of effecting offers or sales of Registrable Shares pursuant thereto, then the right of the selling Investors to use the Registration Statement (and the prospectus relating thereto) for purposes of effecting offers or sales of Registrable
Shares pursuant thereto shall be suspended for a period (a “Suspension Period”) of not more than 30 days after delivery by the Company of the certificate referred to above in this Section 11; provided, however, that
sales shall not be suspended for more than 60 days in any twelve-month period. During a Suspension Period, none of the Investors shall offer or sell any Registrable Shares pursuant to or in reliance upon the Registration Statement (or the prospectus
relating thereto). 
  
 12. TRANSFER OF REGISTRATION RIGHTS.
None of the rights of any Investor under this Agreement shall be transferred or assigned to any person unless (i) such person is a Qualifying Holder (as defined below), and (ii) such person agrees to become a party to, and bound 

  

 8 

 
by, all of the terms and conditions of, this Agreement by duly executing and delivering to the Company an Instrument of Adherence in the form attached as
Exhibit B hereto. For purposes of this Section 12, the term “Qualifying Holder” shall mean, with respect to any Investor, (i) any partner thereof, (ii) any corporation, partnership controlling, controlled by, or under
common control with, such Investor or any partner thereof, or (iii) any other direct transferee from such Investor of at least 50% of those Registrable Shares held or that may be acquired by such Investor. None of the rights of any Investor under
this Agreement shall be transferred or assigned to any Person (including, without limitation, a Qualifying Holder) that acquires Registrable Shares in the event that and to the extent that such Person is eligible to resell such Registrable Shares
pursuant to Rule 144(k) of the Securities Act or may otherwise resell such Registrable Shares pursuant to an exemption from the registration provisions of the Securities Act. 
  
 13. ENTIRE AGREEMENT. This Agreement constitutes and contains the entire agreement and understanding of the parties
with respect to the subject matter hereof, and it also supersedes any and all prior negotiations, correspondence, agreements or understandings with respect to the subject matter hereof. 
  
 14. MISCELLANEOUS. 
  
 (a) This Agreement may not be amended, modified or terminated, and no rights or provisions may be waived, except with the written consent of the Majority
Holders and the Company. 
  
 (b) This Agreement shall be governed
by and construed and enforced in accordance with the laws of the State of New York without regard to the choice of law principles thereof, and shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, personal
representatives, successors or assigns, provided that the terms and conditions of Section 12 hereof are satisfied. This Agreement shall also be binding upon and inure to the benefit of any transferee of any of the Purchased Shares
provided that the terms and conditions of Section 12 hereof are satisfied. Notwithstanding anything in this Agreement to the contrary, if at any time any Investor shall cease to own any Purchased Shares, all of such Investor’s rights
under this Agreement shall immediately terminate. Each of the parties hereto irrevocably submits to the exclusive jurisdiction of the courts of the State of New York located in New York County and the United States District Court for the Southern
District of New York for the purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement and the transactions contemplated hereby. Service of process in connection with any such suit, action or proceeding may be
served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices under this Agreement. Each of the parties hereto irrevocably consents to the jurisdiction of any such court in any such suit, action or
proceeding and to the laying of venue in such court. Each party hereto irrevocably waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts and irrevocably waives any claim that any such suit, action
or proceeding brought in any such court has been brought in an inconvenient forum. 
  
 (c) (i) Any notices, reports or other correspondence (hereinafter collectively referred to as “correspondence”) required or permitted to be given hereunder shall be sent by courier (overnight or same
day) or telecopy or delivered by hand to the party to whom such correspondence is required or permitted to be given hereunder. The date of giving any notice shall be the date of its actual receipt. 
  

 9 

 (ii) All correspondence to the Company shall be addressed as follows: 
  
 Regeneration Technologies, Inc. 
 11621 Research Circle 
 Alachua, Florida 32615 
 Attn: Brian K. Hutchison, President and Chief Executive Officer 
 Telecopier: 386-418-3608 
  
 with a copy (which shall not constitute notice) to: 
  
 Fulbright & Jaworski L.L.P. 
 666 Fifth Avenue 
 New York, New York 10103 
 Attention: Warren J. Nimetz, Esq. 
 Telecopier: 212-318-3400 
  
 (iii) All correspondence to any Investor shall be sent to such Purchaser at the address set forth in Exhibit A. 

 
 (d) Any entity may change the address to which correspondence to it is to
be addressed by notification as provided for herein. 
  
 (e) The
parties acknowledge and agree that in the event of any breach of this Agreement, remedies at law may be inadequate, and each of the parties hereto shall be entitled to seek specific performance of the obligations of the other parties hereto and such
appropriate injunctive relief as may be granted by a court of competent jurisdiction. 
  
 (f) This Agreement may be executed in a number of counterparts, any of which together shall for all purposes constitute one Agreement, binding on all the parties hereto notwithstanding that all such parties have not
signed the same counterpart. 
  

 10 

 IN WITNESS WHEREOF, the parties hereto have executed this Registration Rights Agreement as of the date
and year first above written. 
  

			
	REGENERATION TECHNOLOGIES, INC.
		
	By:	 	 /s/ Brian K. Hutchison

	Name:	 	Brian K. Hutchison
	Title:	 	Chairman, President and Chief Executive Officer

  
 THE INITIAL INVESTOR’S
SIGNATURE TO THE INVESTOR QUESTIONNAIRE DATED EVEN DATE HEREWITH SHALL CONSTITUTE THE INITIAL INVESTOR’S SIGNATURE TO THIS REGISTRATION RIGHTS AGREEMENT. 
  

 -11- 

 EXHIBIT A 
 Name and Address 
  

			
	
	OFIL PLC U.S. Emerging Growth Fund
		
	 1)      Address for correspondence:
 OppenheimerFunds, Inc.
 6803 South
Tucson Way
 Centennial, CO 80112
	  	 2)      Address to deliver the stock certificate:
 JP Morgan Chase
 4 New York
Plaza
 Ground Floor Window
 New York, NY 10004
 Attn: Physical Securities Processing
 Fund Name: PLC US Emerging Growth Fund
 Custodian Domestic a/c # P84929

	
	USAZ Oppenheimer Emerging Growth Fund
		
	 1)      Address for correspondence:
 OppenheimerFunds, Inc.
 6803 South
Tucson Way
 Centennial, CO 80112
	  	 2)      Address to deliver the stock certificate:
 The Northern Trust Company
 40 Broad
Street, 8th Floor
 New York, NY 10004
 Northern Acct. AZO01 – USAZ
 Oppenheimer Emerging Growth Fund

	
	Oppenheimer Discovery Fund
		
	 1)      Address for correspondence:
 OppenheimerFunds, Inc.
 6803 South
Tucson Way
 Centennial, CO 80112
	  	 2)      Address to deliver the stock certificate:
 Citibank
 DTC NY Window
 55 Water Street
 3rd Floor Mezzanine
 New York, NY 10041
 Fund Name: Oppenheimer Discovery Fund
 Custodian a/c # 849890

	
	Oppenheimer Emerging Growth Fund
		
	 1)      Address for correspondence:
 OppenheimerFunds, Inc.
 6803 South
Tucson Way
 Centennial, CO 80112
	  	 2)      Address to deliver the stock certificate:
 Citibank
 DTC NY Window
 55 Water Street
 3rd Floor Mezzanine
 New York, NY 10041
 Fund Name: Oppenheimer Emerging Growth Fund
 Custodian a/c # 849910

			
	 
		
	Henry C. Beinstein	  	 
		
	 1)      Address for correspondence:
 207 Madison Rd.
 Scarsdale, NY
10583
	  	 2)      Address to deliver the stock certificate:
 1370 Avenue of the Americas
 24th Floor
 New York, NY 10019
 Attn: Sue Ann Murray/Susan Grant

	
	Upland Associates L.P.
		
	 1)      Address for correspondence:
 Upland Associates L.P.
 1370 Avenue of
the Americas
 New York, NY 10019
 Attn: Dwight Lee, Manager
	  	 2)      Address to deliver the stock certificate:
 1370 Avenue of the Americas
 New York,
NY 10019
 Attn: Susan Grant/Susan Grant

	
	Neil J. Gagnon
		
	 1)      Address for correspondence:
 127 Mosle Rd
 Mendham, NJ
07945
	  	 2)      Address to deliver the stock certificate:
 1370 Avenue of the Americas
 24th Floor
 New York, NY 10019
 Attn: Sue Ann Murray/Susan Grant

	
	Lois E. Gagnon
		
	 1)      Address for correspondence:
 127 Mosle Rd
 Mendham, NJ
07945
	  	 2)      Address to deliver the stock certificate:
 1370 Avenue of the Americas
 24th Floor
 New York, NY 10019
 Attn: Sue Ann Murray/Susan Grant

	
	The Lois E. and Neil J. Gagnon Foundation
		
	 1)      Address for correspondence:
 The Lois E. and Neil J. Gagnon Foundation
 P.O. Box 691 Bernardsville, NJ 07924
 Attn: Neil Gagnon, Trustee
	  	 2)      Address to deliver the stock certificate:
 1370 Avenue of the Americas
 24th Floor
 New York, NY 10019
 Attn: Sue Ann Murray/Susan Grant

			
	Gagnon Family Partnership
		
	 1)      Address for correspondence:
 Gagnon Family Partnership
 P.O. Box
691
 Bernardsville, NJ 07924
 Attn: Neil Gagnon, General Partner
	  	 2)      Address to deliver the stock certificate:
 1370 Avenue of the Americas
 24th Floor
 New York, NY 10019
 Attn: Sue Ann Murray/Susan Grant

	
	Gagnon Investment Associates
		
	 1)      Address for correspondence:
 Gagnon Investment Associates
 1370
Avenue of the Americas
 New York, NY 10019
 Attn: Neil Gagnon, Manager
	  	 2)      Address to deliver the stock certificate:
 1370 Avenue of the Americas
 24th Floor
 New York, NY 10019
 Attn: Sue Ann Murray/Susan Grant

	
	Gagnon 1999 Grandchildren’s Trust STS 2/1/99 Maureen Drew, TTEE
		
	 1)      Address for correspondence:
 Gagnon 1999 Grandchildren’s Trust STS
 2/1/99 Maureen Drew, TTEE
 P.O. Box 691
 Bernardsville, NJ 07924
 Attn: Maureen Drew, Trustee
	  	 2)      Address to deliver the stock certificate:
 1370 Avenue of the Americas
 24th Floor
 New York, NY 10019
 Attn: Sue Ann Murray/Susan Grant

	
	Zeke L.P.
		
	 1)      Address for correspondence:
 Zeke L.P.
 1235 Westlakes Drive, Suite
330
 Berwyn, PA 19312
 Attn: Edward Antoian, GP
	  	 2)      Address to deliver the stock certificate:
 Chartwell Investment Partners
 1235
Westlakes Drive
 Suite 400
 Berwyn, PA 19312
 Attn: Filippa DePaolo

	
	MedCap Partners L.P.
		
	 1)      Address for correspondence:
 MedCap Partners, L.P.
 500 Third
Street, Suite 535
 San Francisco, CA 94107
 Attn: C. Fred Toney
	  	 2)      Address to deliver the stock certificate:
 MedCap Management & Research LLC
 500 Third Street, Suite 535
 San Francisco, CA 94107
 Attn: C. Fred Toney

			
	MedCap Master Fund L.P.
		
	 1)      Address for correspondence:
 MedCap Master Fund, L.P.
 500 Third
Street, Suite 535
 San Francisco, CA 94107
 Attn: C. Fred Toney
	  	 2)      Address to deliver the stock certificate:
 MedCap Management & Research LLC
 500 Third Street, Suite 535
 San Francisco, CA 94107
 Attn: C. Fred Toney

	
	Capital Ventures International
		
	 1)      Address for correspondence:
 Capital Ventures International
 c/o
Heights Capital Management, Inc.
 101 California Street, Suite 3250
 San Francisco, CA 94111
 Attn: Michael
Spolan
	  	 2)      Address to deliver the stock certificate:
 Capital Ventures International
 401
City Line Avenue, Suite 220
 Bala Cynwyd, PA 19004
 Attn: Tricia Healy

	
	Special Situation Cayman Fund L.P.
		
	 1)      Address for correspondence:
 Special Situation Cayman Fund, L.P.
 153 East 53rd Street
 51st Floor
 New York, NY 10022
 Attn: Austin W.
Marxe,
 Managing General Partner
	  	 2)      Address to deliver the stock certificate:
 Lowenstein Sandler PC
 65 Livingston
Avenue
 Roseland, NJ 07068-1791
 Attn: Jeff Shapiro, Esq.

	
	Special Situation Fund III L.P.
		
	 1)      Address for correspondence:
 Special Situation Fund III L.P.
 153
East 53rd Street
 51st Floor
 New York, NY 10022
 Attn: Austin W.
Marxe,
 Managing General Partner
	  	 2)      Address to deliver the stock certificate:
 Lowenstein Sandler PC
 65 Livingston
Avenue
 Roseland, NJ 07068-179
 Attn: Jeff Shapiro, Esq.

 EXHIBIT B 
  
 Instrument of Adherence 
  
 Reference is hereby made to that certain Registration Rights Agreement, dated as of August     ,
2005, among Regeneration Technologies, Inc., a Delaware corporation (the “Company”), the Initial Investors and the Investor Permitted Transferees, as amended and in effect from time to time (the “Registration Rights
Agreement”). Capitalized terms used herein without definition shall have the respective meanings ascribed thereto in the Registration Rights Agreement. 
  

The undersigned, in order to become the owner or holder of [            ] shares of
common stock, par value $0.001 per share (the “Common Stock”), of the Company, hereby agrees that, from and after the date hereof, the undersigned has become a party to the Registration Rights Agreement in the capacity of an
Investor Permitted Transferee, and is entitled to all of the benefits under, and is subject to all of the obligations, restrictions and limitations set forth in, the Registration Rights Agreement that are applicable to Investor Permitted
Transferees. This Instrument of Adherence shall take effect and shall become a part of the Registration Rights Agreement immediately upon execution. 
  
 Executed under seal as of the date set forth below under the laws of
                    . 
  

			
	Signature:	 	  

	Name:	 	 
	Title:	 	 

  
 Accepted: 
  

			
	 REGENERATION TECHNOLOGIES, INC.

		
	By:	 	  

	Name:	 	 
	Title:	 	 
		
	Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}]]